Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2026-02-20 @ 6:39 PM
Study NCT ID:
NCT02414750
Status:
TERMINATED
Last Update Posted:
2022-11-30
First Post:
2015-02-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vemurafenib Plus Cobimetinib in Metastatic Melanoma
Sponsor:
Netherlands Working Group on Immunotherapy of Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12
Start Date Type:
None
Primary Completion Date:
2020-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-11
First Submit QC Date:
None
Study First Post Date:
2015-04-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-24
Last Update Post Date:
2022-11-30
Last Update Post Date Type:
ACTUAL